The Digital Pharma
Curing incurable diseases and
increasing humanity’s longevity
Life science industry fails to
leverage data at scale
![Drug-development](/wp-content/uploads/2023/03/Drug-development.png)
Drug development process is...
Slow
~85%
from drug discovery to approval
Inefficient
~85%
of biomedical research is wasted
Risky
~90%
risk of failure in clinical trials
Key data challenges are...
Accessibility
Data is hidden in silos within organization
Ownership
Patients have no stake in use of their data
Insights
Pharma, Biotechs fail to access valuable healthcare data
![key-data](/wp-content/uploads/2023/03/key-data.png)
Our Solution
Revolutionizing drug development through a platform driven
by big data, AI and blockchain
Three Pillars of our platform
From data to drug assets
![3-Pillars](/wp-content/uploads/2023/03/3-Pillars.png)
Data
The first and largest equitable patient data exchange built on an app ecosystem and institutional partnerships
Decision making
Contextual AI-based decision making validating and improving AI predictions with experimental capabilities
Drug assets
AI-based, at scale identification of overlooked pharma assets and acceleration towards value inflection
Who we partner with
![Biotech-icon](/wp-content/uploads/2023/03/Biotech-icon.png)
Biotechs
![Pharma-icon](/wp-content/uploads/2023/03/Pharma-icon.png)
Pharma
![CRO-icon](/wp-content/uploads/2023/03/CRO-icon.png)
CROs
![Academic-icon](/wp-content/uploads/2023/03/Academic-icon.png)
Academics
![Patient-icon](/wp-content/uploads/2023/03/Patient-icon.png)
Patients
We work with top players in the Life Sciences industry from across
the world to bring new drugs to patients faster
the world to bring new drugs to patients faster
OUR TEAM
Combining world-class experience in entrepreneurship,
life sciences, medicine and technology.
BOARD MEMBERS
![innoplexus-people](/wp-content/uploads/2022/11/innoplexus-people.png)
Francisco
Fernandez
Founder & Chairman
![innoplexus-people](/wp-content/uploads/2021/12/Gunjan_Bhardwaj_1-3.jpeg)
Dr. Gunjan
Bhardwaj
Founder & CEO
![innoplexus-people](/wp-content/uploads/2023/03/Dr.-Keren-Paul-Zimmer.png)
Dr. Karen Paul
Zimmer, MD, MPH
Board Member
Our latest News
![](/wp-content/uploads/2021/12/Partex_symbol.png)
Partex & Singapore’s EDDC collaborate to bring forward an innovative approach for early drug discovery & development
![](/wp-content/uploads/2021/12/Partex_symbol.png)
![](/wp-content/uploads/2024/04/Partex-Lupin-press-release.png)
Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation
![](/wp-content/uploads/2021/12/Partex_symbol.png)
![](/wp-content/uploads/2024/03/Althea-logo.png)
![](/wp-content/uploads/2024/03/Althea-logo.png)
Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development
![](/wp-content/uploads/2021/12/Partex_symbol.png)
![](/wp-content/uploads/2024/01/AIO-partner-logo.png)
![](/wp-content/uploads/2024/01/AIO-logo.png)
AIO-Studien-gGmbH and Amrit – a Partex Company are jointly announcing the start of a pilot project as part of the AIO data hub initiative
![](/wp-content/uploads/2021/12/Partex_symbol.png)
![](/wp-content/uploads/2023/08/parexel_logo.png)
![](/wp-content/uploads/2023/08/parexel_logo.png)
Parexel and Partex announce innovative partnership leveraging AI & big data to accelerate drug discovery & development